Hemoglobinopathy Nursing Program and Pediatric Nursing Students

NCT05389891 | Completed

• 1 other identifier: PediaMarch201601
• Study Type: interventional
• Target: 108
• Locations: 1 country
• Sites: 1

Brief Summary

Hemoglobinopathies are the most common life threatening, monogenic disorders in the world. The most common causes of hemoglobinopathies are sickle cell disease and thalassemia. Aim: This study aimed to evaluate the effect of a hemoglobinopathy nursing program on pediatric nursing students' performance.

Conditions

Hemoglobinopathies; Thalassemia; Sickle Cell Disease; Nurse's Role

Outcome Measures

Primary Outcomes (3)

• Pediatric nursing students' awareness

  Measure Students' awareness through: 01\. Personal Data and PNSs' Awareness Questionnaire -sixty (60) questions. A score of (one) for correct answers, and (zero) for the wrong answers. The total scores ranged from (0-60 mark).

  10 weeks

• Pediatric nursing students' Attitude

  Pediatric nursing students' Attitude Scale \- nine (9) questions. A five-point Likert scale by give a score of (four) for Strongly Agree, (three) for Agree, (two) for Undecided, (one) for Disagree and (zero) for Strongly Disagree. The total score ranged from (0-36 mark).

  10 weeks

• Pediatric nursing students' Practice

  Observational Checklists - forty (40) items. A score of (two) for completely done, (one) for incompletely done and (zero) for not done. The total score ranged from (0-80 mark), scores less than 60% were considered incompetent practice.

  10 weeks

Study Arms (2)

Group 1

EXPERIMENTAL

Experimental Group (n=54) The implementation phase was achieved through sessions within Feb-April2017 second semester of the academic year 2016/2017.Each session started by the objectives of the new session and summary of previous one. Motivation and reinforcement during session were used to enhance participation and sharing in this study. The researcher did the explanation of the questionnaire sheet to the pediatric student nurses to assess their awareness and attitude toward hemoglobinopathies. The researcher observed the pediatric student nurses 'practice during applying blood transfusion, subcutaneous medication administration, and oral medication administration using the observational checklist at faculty laboratory.

Other: Hemoglobinopathy Nursing Program

Group 2

NO INTERVENTION

Control Group (n=54) The researcher did the explanation of the questionnaire sheet to the pediatric student nurses to assess their awareness and attitude toward hemoglobinopathies. The researcher observed the pediatric student nurses 'practice during applying blood transfusion, subcutaneous medication administration, and oral medication administration using the observational checklist at faculty laboratory.

Interventions

Hemoglobinopathy Nursing Program OTHER

"Hemoglobinopathy Nursing Program" is more informative for "Groupe 1" than "Group 2"

Group 1

Eligibility Criteria

• Age: 19 Years - 22 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• pediatric nursing students registered for the academic year 2016/2017

You may not qualify if:

• Any student had personal or family history of hemoglobinopathies

Sponsors & Collaborators

• Beni-Suef University: lead
• Benha University: collaborator

Study Sites (1)

Benha University

Banhā, Other, 13511, Egypt

Location

MeSH Terms

Conditions

Hemoglobinopathies; Thalassemia; Anemia, Sickle Cell

Condition Hierarchy (Ancestors)

Hematologic Diseases; Hemic and Lymphatic Diseases; Genetic Diseases, Inborn; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Anemia, Hemolytic, Congenital; Anemia, Hemolytic; Anemia

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: May 12, 2022
• First Posted: May 25, 2022
• Study Start: February 27, 2017
• Primary Completion: April 26, 2017
• Study Completion: May 11, 2017
• Last Updated: May 25, 2022

Record last verified: 2022-05

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL, SAP
• Time Frame: Data requests can be submitted starting 9 months after article publication and the data will be made accessible for up to 24 months. Extensions will be considered on a case-by-case basis.
• Access Criteria: ""Access to trial IPD can be requested by qualified researchers engaging in independent scientific research, and will be provided following review and approval of a research proposal and Statistical Analysis Plan (SAP). For more information or to submit a request, please contact ahmed.loutfy@nursing.bsu.edu.eg"

Locations

EG (1)